Propranolol efficacy as a novel adjuvant for immunization against Toxoplasma gondii tachyzoites

Minaei, S and Ziaali, N and Seyyedi, S and Shahabi, SH and Mohammadzadeh Hajipirloo, H (2018) Propranolol efficacy as a novel adjuvant for immunization against Toxoplasma gondii tachyzoites. Experimental Parasitology, 194. pp. 60-66.

Preview

Text 1179.pdf Download (1MB) | Preview

Abstract

Severe or lethal damages, caused by Toxoplasma gondii infection in congenital cases and immunocompromised patients implies the necessity for development of a vaccine and an appropriate adjuvant would be needed to elicit a protective Th1 biased-immune response. The adjuvant activity of propranolol was surveyed and compared with alum by immunization of BALB/c mice with protein components of T. gondii tachyzoites. Five groups of BALB/c mice were immunized with phosphate buffered saline (negative control), Toxoplasma lysate antigen (TLA), alum plus TLA, Propranolol plus TLA, and alum, propranolol and TLA. Immunization efficacy was evaluated by lymphocyte proliferation and DTH tests, challenge with live tachyzoites, IFN-γ production by spleen cells, serum TNF-α concentration and anti- Toxoplasma total IgG, IgG1 and IgG2a measurements. Mice of the PRP-TLA group induced significantly more IFN-γ and TNF-α production and lymphocyte proliferation than other groups. This group of mice also showed more anti-T. gondii IgG2a and DTH responses and showed a significantly increased survival time after challenge. These findings indicate that propranolol as an adjuvant in combination with TLA, may enhance cellular immunity against T. gondii

Actions (login required)

View Item